| dc.contributor.author |
Stegeman, I |
|
| dc.contributor.author |
Ochodo, EA |
|
| dc.contributor.author |
Guleid, F |
|
| dc.contributor.author |
Holtman, GA |
|
| dc.contributor.author |
Yang, B |
|
| dc.contributor.author |
Davenport, C |
|
| dc.contributor.author |
Deeks, JJ |
|
| dc.contributor.author |
Dinnes, J |
|
| dc.contributor.author |
Dittrich, S |
|
| dc.contributor.author |
Emperador, D |
|
| dc.contributor.author |
Hooft, L |
|
| dc.contributor.author |
Spijker, R |
|
| dc.contributor.author |
Takwoingi, Y |
|
| dc.contributor.author |
Van den Bruel, A |
|
| dc.contributor.author |
Wang, J |
|
| dc.contributor.author |
Langendam, M |
|
| dc.contributor.author |
Verbake, JY |
|
| dc.contributor.author |
Leeflang, MM |
|
| dc.date.accessioned |
2024-07-15T07:56:06Z |
|
| dc.date.available |
2024-07-15T07:56:06Z |
|
| dc.date.issued |
2020-11 |
|
| dc.identifier.uri |
https://doi.org/10.1002%2F14651858.CD013787 |
|
| dc.identifier.uri |
http://repository.kemri.go.ke:8080/xmlui/handle/123456789/695 |
|
| dc.description.abstract |
Background: Specific diagnostic tests to detect severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and resulting COVID-19 disease are not always available
and take time to obtain results. Routine laboratory markers such as white blood cell count,
measures of anticoagulation, C-reactive protein (CRP) and procalcitonin, are used to
assess the clinical status of a patient. These laboratory tests may be useful for the triage of
people with potential COVID-19 to prioritize them for different levels of treatment,
especially in situations where time and resources are limited. |
en_US |
| dc.language.iso |
en |
en_US |
| dc.publisher |
Cochrane Database Syst Rev. |
en_US |
| dc.title |
Cochrane COVID-19 Diagnostic Test Accuracy Group. Routine laboratory testing to determine if a patient has COVID-19. |
en_US |
| dc.type |
Article |
en_US |